arrow
T

Thomas Kuilman

Utrecht University Medical Center
H指数:21
被引数:9,418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies

基于从诊断性肿瘤活检样本高通量TCR发现,实现下一代工程化TCR-T疗法

2025-01-140
OA
An adverse tumor-protective effect of IDO1 inhibition

IDO1抑制的不良肿瘤保护作用

2023-02-0110
OAAI
SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response

SERPINB9通常被扩增,癌细胞中的高表达与免疫检查点阻断反应差相关

2022-11-2916
OA
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4
2021-07-061
OA
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
2018-01-15188
PREAI
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients
2016-07-01123
OAAI
BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
2016-06-0184
OAAI
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

从人类结直肠癌转移灶活检培养的类器官中保留的遗传多样性

2015-10-12386
OAAI
Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms

跨不同数据集和平台重复的样本拷贝数谱的鲁棒BRCA1-like分类

2015-03-2027
OAAI
CopywriteR: DNA copy number detection from off-target sequence data
2015-02-27173
OAAI
Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
2015-01-073
PREAI